Changeflow GovPing Healthcare & Life Sciences Myofascial Pain Trial, Trapezius Trigger Points...
Routine Notice Added Final

Myofascial Pain Trial, Trapezius Trigger Points, Kyrenia Cyprus

Favicon for clinicaltrials.gov ClinicalTrials.gov - Phase 4 Trials
Detected
Email

Summary

A Phase 4 clinical trial investigating myofascial pain syndrome associated with trapezius muscle trigger points has been registered on ClinicalTrials.gov. The trial, identified as NCT07547605, is being conducted in Kyrenia, Cyprus. Healthcare providers and clinical investigators should be aware of this ongoing research in the myofascial pain field.

Published by NIH on clinicaltrials.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov - Phase 4 Trials for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 10 changes logged to date.

What changed

ClinicalTrials.gov has added a Phase 4 clinical trial (NCT07547605) investigating myofascial pain syndrome affecting the trapezius muscle and associated trigger points. The trial is registered as an interventional study being conducted in Kyrenia, Cyprus.

Healthcare providers, clinical investigators, and patients interested in myofascial pain research may wish to review this trial on ClinicalTrials.gov for additional details regarding study design, eligibility criteria, and enrollment information.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Show glossary

Get daily alerts for ClinicalTrials.gov - Phase 4 Trials

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical research Clinical trial registration
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov - Phase 4 Trials publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!